These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 37432155)

  • 1. Cyclitols: From Basic Understanding to Their Association with Neurodegeneration.
    Derkaczew M; Martyniuk P; Osowski A; Wojtkiewicz J
    Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-Promoting Properties of Selected Cyclitols for Metabolic Syndrome and Diabetes.
    Antonowski T; Osowski A; Lahuta L; Górecki R; Rynkiewicz A; Wojtkiewicz J
    Nutrients; 2019 Sep; 11(10):. PubMed ID: 31574903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Healing-Promoting Properties of Selected Cyclitols-A Review.
    Owczarczyk-Saczonek A; Lahuta LB; Ligor M; Placek W; Górecki RJ; Buszewski B
    Nutrients; 2018 Dec; 10(12):. PubMed ID: 30513929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological Properties of Cyclitols and Their Derivatives.
    Şimşek Kuş N
    Chem Biodivers; 2024 Jan; 21(1):e202301064. PubMed ID: 37824100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenously Applied Cyclitols and Biosynthesized Silver Nanoparticles Affect the Soluble Carbohydrate Profiles of Wheat (
    Lahuta LB; Szablińska-Piernik J; Stałanowska K; Horbowicz M; Górecki RJ; Railean V; Pomastowski P; Buszewski B
    Plants (Basel); 2023 Apr; 12(8):. PubMed ID: 37111851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
    Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
    Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.
    Fernández-Ruiz J; Romero J; Ramos JA
    Handb Exp Pharmacol; 2015; 231():233-59. PubMed ID: 26408163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.
    Ciurea AV; Mohan AG; Covache-Busuioc RA; Costin HP; Glavan LA; Corlatescu AD; Saceleanu VM
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Products from Plants and Algae for Treatment of Alzheimer's Disease: A Review.
    Klose J; Griehl C; Roßner S; Schilling S
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [INVESTIGATIONS CONCERNING THE BIOSYNTHESIS OF CYCLITOLS, I. FORMATION OF D-PINITOL, D-INOSITOL AND SEQUOYITOL FROM MESO -INOSITOL IN LEAVES OF TRIFOLIUM INCARNATUM].
    SCHOLDA R; BILLEK G; HOFFMANN-OSTENHOF O
    Hoppe Seylers Z Physiol Chem; 1964; 335():180-6. PubMed ID: 14124981
    [No Abstract]   [Full Text] [Related]  

  • 11. Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders?
    Jodeiri Farshbaf M; Ghaedi K
    Biometals; 2017 Feb; 30(1):1-16. PubMed ID: 27853903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The presymptomatic stage of neurodegenerative disorders].
    Klein C; Hagenah J; Landwehrmeyer B; Münte T; Klockgether T
    Nervenarzt; 2011 Aug; 82(8):994-1001. PubMed ID: 21789693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of Alzheimer's Parkinson's and Huntington's disease. A minireview.
    Antal A; Bodis-Wollner I
    Neurobiology (Bp); 1993; 1(2):101-22. PubMed ID: 8111350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the Explicit Protective Activity of Herbals in Management of Neurodegenerative and Cerebrovascular Disorders.
    Behl T; Makkar R; Sehgal A; Sharma N; Singh S; Albratty M; Najmi A; Meraya AM; Bungau SG
    Molecules; 2022 Aug; 27(15):. PubMed ID: 35956919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
    Mantle D; Falkous G; Ishiura S; Perry RH; Perry EK
    J Neurol Sci; 1995 Jul; 131(1):65-70. PubMed ID: 7561949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurolinguistic features of spontaneous language production dissociate three forms of neurodegenerative disease: Alzheimer's, Huntington's, and Parkinson's.
    Illes J
    Brain Lang; 1989 Nov; 37(4):628-42. PubMed ID: 2479447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inositol trisphosphate receptor Ca2+ release channels in neurological diseases.
    Foskett JK
    Pflugers Arch; 2010 Jul; 460(2):481-94. PubMed ID: 20383523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias.
    Bezprozvanny I
    Neurochem Res; 2011 Jul; 36(7):1186-97. PubMed ID: 21210219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Methodology for the Identification of Metabolites of Saccharides and Cyclitols by Off-Line EC-MALDI-TOF-MS.
    Sagandykova G; Walczak-Skierska J; Monedeiro F; Pomastowski P; Buszewski B
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32722273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.